455 studies found for:    "Pigment-dispersion syndrome"
Show Display Options
Rank Status Study
1 Completed Autoimmune Dysregulation in Pigmentary Glaucoma
Conditions: Pigmentary Glaucoma;   Primary Open Angle Glaucoma;   Cataract
Interventions: Procedure: Trabeculectomy;   Procedure: Trabeculectomy and cataract surgery;   Procedure: Cataract surgery
2 Completed Cause of Pigment Dispersion Syndrome
Conditions: Glaucoma;   Healthy;   Pigment Dispersion Syndrome
Intervention:
3 Completed Pigment Dispersion Syndrome: Natural History and Possible Protective Effect of a YAG Laser Iridotomy
Condition: Pigment Dispersion Syndrome
Intervention: Procedure: Yag laser iridotomy
4 Completed IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty
Conditions: Primary Open Angle Glaucoma;   Pigmentary Glaucoma;   Pseudoexfoliative Glaucoma
Intervention: Device: Sensimed Triggerfish
5 Unknown  Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition
Condition: Glaucoma Open-Angle
Intervention: Procedure: Optic nerve sheath fenestration
6 Active, not recruiting Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
Condition: Open-angle Glaucoma
Interventions: Device: One iStent;   Device: Two iStent
7 Recruiting Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
Conditions: Primary Open Angle Glaucoma;   Pseudoexfoliative Glaucoma;   Pigmentary Glaucoma
Interventions: Device: Hydrus Microstent;   Device: iStent Trabecular Micro Bypass
8 Completed A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension;   Drug: Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT)
9 Recruiting Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
Condition: Open-Angle Glaucoma
Intervention: Device: iStent and iStent supra
10 Active, not recruiting Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
Condition: Open-angle Glaucoma
Interventions: Device: iStent;   Other: SLT
11 Completed Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-angle Glaucoma;   Oular Hypertension
Interventions: Drug: Anecortave Acetate Sterile Suspension, 30 mg/mL;   Drug: Anecortave Acetate Sterile Suspension, 60 mg/mL;   Drug: Anecortave Acetate Sterile Suspension, 75 mg/mL;   Other: Anecortave Acetate Vehicle
12 Unknown  Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma
Condition: Open Angle Glaucoma
Interventions: Procedure: Trabectome +/- Cataract Surgery;   Procedure: Trabeculectomy with Mitomycin C +/- Cataract Surgery
13 Completed Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma
Condition: Open-Angle Glaucoma
Intervention:
14 Completed A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia
Conditions: Open Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: timolol;   Drug: PhXA41
15 Completed Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: Xalatan
16 Unknown  Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications
Conditions: Open-Angle Glaucoma;   Surgery
Intervention: Procedure: Goniocurettage
17 Completed Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-angle Glaucoma;   Ocular Hypertension
Intervention: Drug: Travoprost/Timolol Maleate Fixed Combination solution
18 Completed A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom
Conditions: Ocular Hypertension;   Open Angle Glaucoma
Interventions: Drug: timolol;   Drug: PhXA41
19 Terminated A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Anecortave Acetate Sterile Suspension, 6 mg/mL;   Drug: Anecortave Acetate Sterile Suspension, 3.75 mg/mL;   Drug: Anecortave Acetate Sterile Suspension, 96 mg/mL;   Drug: Anecortave Acetate Sterile Suspension, 60 mg/ML;   Other: Anecortave Acetate Vehicle
20 Completed Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Ocular Hypertension;   Open-angle Glaucoma
Interventions: Drug: Travoprost ophthalmic solution (new formulation);   Drug: Travoprost ophthalmic solution, 0.004%;   Drug: Vehicle

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years